Skip to main content
  1. Home
  2. Emerging Tech
  3. Health & Fitness
  4. News

Algorithm predicts Parkinson’s disease by digging through your medical history

Add as a preferred source on Google

As a progressive degenerative disorder that predominantly affects motor abilities, patients with Parkinson’s disease are instantly recognizable to physicians based on their distinctive symptoms — which can include tremors, slowness of movement, and even changes to a person’s handwriting. The problem is that these symptoms only develop after a person has been successfully diagnosed.

At present, there is no reliable way to consistently identify people who are on track to develop the neurological disorder. This can make it difficult to get them the treatment they need early on, while subjecting patients to multiple tests as doctors search for the root of the problems they report. Researchers at the Washington University School of Medicine in St. Louis think they’ve come up with a solution, however — by developing algorithm that’s able to accurately predict whether a patient will be diagnosed with Parkinson’s. To do this, it looks for signs in a patient’s medical history, which may otherwise be overlooked.

Recommended Videos

“We started [developing our algorithm by using] demographic factors already known to be associated with the development of Parkinson’s disease — age, sex, race, and tobacco smoking history — and then added to it a simplified medical history,” Brad Racette, professor of neurology at Washington University School of Medicine, told Digital Trends. “Specifically, we started with 26,468 codes for diagnoses or medical procedures they had received in the past five years. Then we identified which of those codes also were predictive of PD. The final stage of the model development allowed us to compress this list down to the 536 codes that were both the most informative in our dataset, and also the most likely to be useful in future datasets.”

The algorithm proved 73 percent accurate when it came to identifying individuals who would be diagnosed with the disease, based on a test data set from 2009. It was also 83 percent accurate at predicting who would not be diagnosed with the disease. Factors in a person’s medical history which can indicate Parkinson’s include gastrointestinal problems, sleep disturbances, fatigue, weight loss, and more — many of which may not immediately make physicians think of Parkinson’s as a potential cause.

Washington University’s study isn’t the only high tech approach to diagnosing and treating Parkinson’s disease that we’ve covered. With 1 million Americans living with Parkinson’s disease, and an estimated 10 million worldwide, this is a disease that has attracted plenty of research — from attempts to treat it by reprogramming cells in the brain to the use of sensor-packed belts to help patients overcome the symptoms. Hopefully, an early diagnosis tool such as this one can play a valuable role alongside these other treatments.

A paper describing the work was recently published in the journal Neurology.

Luke Dormehl
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Checking body medication levels may now be as easy as sucking on a peach-flavoured lollipop
Forget the clinic swab; this lollipop wants a lick
Lollylab

Checking your body’s medication levels is usually no one’s idea of fun. Now researchers are trying to change that with Lollylab, a candy-coated, lollipop-like device that can collect saliva and measure levels of acetaminophen in under two minutes.

The prototype created by researchers whose work was published in ACS Sensors transforms a familiar object into a miniature testing device. In a pilot study, six adults ingested the peach-flavored Lollylab before and one hour after a standard 650-milligram dose of acetaminophen. The device repeatedly detected the pain reliever in their saliva, and participants reported it was more comfortable and easier to use than traditional saliva swabs.

Read more
A US state just approved an AI doctor. For now, it’ll only prescribe acne cures.
Aside from acne, Nolla's AI can also handle redness, fine lines and wrinkles, hyperpigmentation and dark spots, and under-eye bags.
Nolla Derm AI doctor app.

The first AI doctor is here. Despite all the skepticism and risks associated with AI models going haywire, the state of Utah just approved Nolla Health, a company that is providing an AI healthcare expert capable of writing prescriptions without any human in the chain. For now, it will only write acne prescriptions for Utah residents over 18 years of age, willing to pay a token monthly subscription fee that's lighter than your Spotify bill.

The big push here is that the Nolla Derm app will reduce the costs of medical consultation, save users the hassle of clinic visits, and take out the problem of waitlisting from the entire healthcare equation. “Unlike telehealth platforms that use AI only to collect information before handing patients off to clinicians, Nolla's AI system is designed to independently issue initial prescriptions within tightly defined, physician-approved treatment protocols,” writes the company. 

Read more
AI’s massive appetite could make cheap smartphones much harder to find
The smartphone aisle is getting pricier, and AI may be partly to blame.
Electronics, Mobile Phone, Phone

Buying a genuinely cheap smartphone could soon become a lot harder, and the reason has little to do with what’s happening inside the smartphone industry itself. The enormous amount of hardware being poured into AI data centers is pressuring global memory supplies. That has helped drive up the cost of making phones, and manufacturers appear increasingly reluctant to absorb those extra costs at the cheapest end of the market.

According to Counterpoint Research, prices of existing smartphones have increased by around 15% globally this year, while newly launched devices are roughly 25% more expensive than comparable models from last year. The impact hasn't been equal everywhere, either. Smartphone prices have climbed 21% in India and 19% across Asia-Pacific, compared with just 5% in the US.

Read more